GBA1 and Parkinson disease: However, GBA-PD patients (N370S being the most common) show higher rates of dementia, RBD and psychosis while dual mutation carriers have the least RBD and psychosis, suggesting that LRRK2 G2019S may exert a protective effect among patients with GBA mutations.